The Patent Litigation Europe Summit
Monday, January 19, 2026 -- Wednesday, January 21, 2026, 0900 - 1800
The Patent Litigation Europe Summit 2026 will take place from 19–21 January 2026 at the Beurs van Berlage in Amsterdam, Netherlands, bringing together Europe's most influential patent litigators, in-house counsel, judges, policymakers, and industry innovators. Formerly known as the Pharma and Biotech Patent Litigation Summit, the event has evolved into the Patent Litigation Europe Summit, now encompassing both the established Pharma and Biotech Patent Litigation Europe stream and the brand-new Tech and Innovation Patent Litigation Europe stream. This rebrand reflects the growing convergence between life sciences and technology sectors and their shared challenges within the Unified Patent Court (UPC) and wider global enforcement landscape.
The event opens on Monday 19 January with the UPC Litigation Forum, a full-day cross-sector pre-conference dedicated to deep analysis of early UPC rulings, procedural developments, and judicial insights. Sessions will explore the doctrine of equivalents, claim construction, injunction strategies, and the evolving reach of the UPC's jurisdiction. Featuring UPC judges and leading counsel, this pre-day forum provides an exclusive opportunity for attendees to understand the decision-making processes shaping Europe's newest patent court and to benchmark their litigation strategy against peers across industries.
From Tuesday 20 to Wednesday 21 January, the summit divides into two concurrent tracks, allowing attendees to tailor their experience according to their sector focus.
The Pharma and Biotech Patent Litigation Europe stream returns for its fifth year as the region's premier meeting for innovators, biosimilar manufacturers, and generic companies. Topics include cross-border litigation strategy, second medical use case law, plausibility following G2/21, SPC and PTE litigation, Bolar exemptions, and the evolving impact of the proposed EU pharmaceutical package. Sessions led by senior in-house counsel and judges will address pressing challenges such as preliminary injunctions in fast-moving markets, regulatory exclusivity, illicit compounding, and settlement strategy in a post-UPC world. This track attracts IP leaders from companies such as Sandoz, Fresenius Kabi, MSD, Novartis, Novo Nordisk, Regeneron, and Bayer, offering a uniquely balanced discussion across the innovator and generic sides of the market.
Running in parallel, the Tech and Innovation Patent Litigation Europe stream debuts in 2026, reflecting Europe's rapidly expanding litigation landscape in technology, telecommunications, automotive, and consumer electronics. The agenda explores SEP and FRAND enforcement, AI-related IP disputes, trade secrets, injunction power in key jurisdictions, and cross-border forum selection under the UPC and national courts. With participation from leading global IP figures including Nokia, Ericsson, Qualcomm, Xiaomi, Huawei, Cisco, TomTom, and ASML, this stream provides an unparalleled opportunity to understand the dynamics of patent monetisation, global FRAND rate setting, and regulatory developments shaping licensing and enforcement.
Across both tracks, the event maintains a 45% in-house counsel ratio, ensuring attendees benefit from commercially valuable networking and insight exchange with decision-makers who drive litigation and instruct external counsel. The summit attracts over 800 professionals, including corporate IP leaders, patent litigation partners from top European and international firms, litigation funders, and regulatory specialists. Delegates have access to shared networking spaces, curated roundtable discussions, and pre-scheduled one-to-one meetings, fostering meaningful new business connections and collaboration opportunities.
Key confirmed speakers and panellists include Julia Pike (Sandoz), Corinna Sundermann (Fresenius Kabi), James Horgan (MSD), Ronny Thomas (UPC Local Division Judge), Clemens Heusch (Nokia), Gabriele Mohsler (Ericsson), Le Chen (Xiaomi), Georg Müller (TomTom), Ief Daems (Cisco), and Wolfram Thomas (Qualcomm), alongside UPC judges from the Courts of Appeal and First Instance. Their participation underscores the summit's reputation as the foremost forum for discussion and practical guidance on European patent litigation.
URLs:
Website: https://go.evvnt.com/3302704-0?pid=2874
Exhibitor: https://go.evvnt.com/3302704-4?pid=2874
Category: Conferences | Business and Economics | Legal
Prices:
Tier 1 - In-House Counsel: EUR 499.00,
Tier 2 - Private Practice: EUR 1999.00,
Tier 3 - Solution Providers: EUR 2999.00
Speakers: Adrian Spillmann, Director of IP, Valneva, Andreas Robinson, Senior Counsel- IP and Litigation Law, Amgen, Beatriz Diaz de Escauriaza, Head of IP Legal, Insud Pharma, Carsten Richter, Head of Division IP, Euroimmun, Cecile Teles, Head of IP, Zentiva, Christoph Rehfuess, Head of IP, Sotio, Corinna Sundermann, Fresenius Kabi, Elisabeth Haselhorst, IP Litigation Counsel, Bayer, Ewan Nettleton, Principal IP Counsel- Oncology Litigation, Novartis, Fiona Bor, VP- Intellectual Property, Bicycle Therapeutics, George Moore, Assistant General Counsel, Viatris, Guido Pontremoli, Vice President Global IP, Chiesi, James Horgan, Chief IP Counsel- Policy and Litigation, MSD, James Robertson, Head of Global IP, bioMérieux, Julia Pike, Global Head of IP, Sandoz, Karin Pramberger, Head of IP, Polpharma, Katherine Hinterburg, Senior Director- Patent Litigation, Moderna, Konstantina Koriatopoulou, Director of IP, Elpen, Laila Beynon, Regeneron, Manuel Neetz, IP Counsel, Siemens Healthineers, Markus Gruber, Head IP Solid Tumours and Radioligland Therapies, Novartis, Matthew O'Neill, Head of IP, Glenmark, Michal Porubsky, Associate General Counsel, Novo Nordisk, Philippe Bessiere, Global Head of Patents, Pierre Fabre, Raquel Frisardi, Associate General Counsel, Novo Nordisk, Sean Alexander, Head of IP, Umicore, Shohta Ueno, Associate General Counsel- Dispute Resolution, Regeneron, Toni Santamaria, Chief IP Officer, Adalvo, Aoife Murphy, Partner, DLA Piper, Aude Veinante – Partner, Lavoix, Axel Berger, Partner, Bardehle Pagenberg, Camille Pecnard – Partner, Lavoix, Chris, Dudzinski, Parner, SDP, Claudia Milbradt, Partner, Clifford Chance, Dan McGrath, Managing Associate, Marks and Clark, Daniel Hoppe, Partner, Bonabry, Daniel Lim, Partner, Kirkland and Ellis, Dawid Sierzant, Partner, SDP Legal, Eleanor Root, Partner, Bird and Bird, Emre Kerim Yardımcı, Senior Partner, Deris, Eva Ehlich, Partner, Maiwald, James Holtom, Partner, McCarthy Tetrault, Jin Ooi, Partner, Kirkland and Ellis, John Cox Partner, Barnes and Thornburg, Katherine Helm, Partner, Dechert, Kokularajah Paheenthararajah, Partner, DLA Piper, Lauren Baker, Partner, Barnes and Thornburg, Maria Balestriero, of Counsel, Portolano Cavallo, Mariusz Kondrat, Managing Partner, Kondrat and Partners, Mike Gilbert, Partner, Marks and Clark, Okan Can, Senior Partner, Deris, Özge Atılgan Karakulak, Partner, Gun and Partners, Paul Ainsworth, Director, Sterne Kessler, Paul Inman, Partner, Gowling, Peter Van Schijndel, Partner, Hoyng Rokh Monegier, Pierre-Emmanuel Meynard – Partner, Lavoix, Richard Roberts, Partner, Potter Clarkson, Rob Rodrigues, Partner, RNA Law, Rutger Kleemans, Partner, Freshfields, Sebastian Moore, Partner, HSF Kramer, Selin Sinem Erciyas, Partner, Gun and Partners, Selma Ünlü, Senior Partner, NSN Law Firm, Siddharth Kusumakar, Partner, Powell Gilbert, Viviane Kunisawa, Partner, Daniel Law, Adele Calamo Specchia, Head of Ownership and Licensing, ASML, Adrian Howes,Head of IP and Standards- IP Policy, Nokia, Alexander Haertel, Cluster Lead Patents, Deutsch Telekom, Bas Van Buul, Director of IP, Inalfa Roof Systems, Beatriz Diaz de Escauriaza, Head of IP Legal, Insud Pharma, Bita Mortazavi, Vice President, Patent Analysis, RPX, Clemens Heusch, Global Head of Dispute Resolution, Nokia, David Goodfellow, Chief IP Counsel, Aptiv, Ewan Nettleton, Principal IP Counsel- Oncology Litigation, Novartis, Farnaz Massoumian, Senior Patent Attorney, Vodafone, Gabriele Mohsler, VP Patent Development, Ericsson, Georg Muller, Head of IP, Tom Tom, Ief Daems, Associate General Counsel, Cisco, Jako Elevald, Head of IP Licensing, Philips, Julia Dias, Senior IP Policy Counsel, Huawei, Koenraad Wuyds, Chief IP Officer, KPN, Le Chen, Senior Director- IP Policy and Dispute Resolution, Xiaomi Technology, Louis Ross, CEO, MEI Micro, Manuel Neetz, IP Counsel, Siemens Healthineers, Mitsuaki Masumura, Head of Licensing EMEA, IBM, Sean Alexander, Head of IP, Umicore, Taylor Ludlam, VP- IP and Litigation, Lenovo, Tom Brown, Head of IP Litigation, Dell, Wolfram Thomas, Senior Director- Patent Counsel, Qualcomm, Yann Dietrich, Group Head of IP, Atos, Antje Brambrink, Partner, Finnegan, Aude Veinante – Partner, Lavoix, Ben Elacqua, Principal, Fish and Richardson, Camille Pecnard – Partner, Lavoix, Carl-Alexander Dinges, Partner, Bonabry, Daan de Lange, Partner, Brinkhof, Dan McGrath, Managing Associate, Marks and Clark, Emily Bottle, Partner, HSF Kramer, Florian Schmidt-Bogatzky, Partner, HSF Kramer, Gary Moss, Chairman, EIP, Julia Schönbohm, Partner, Linklaters, Julia Zhu, Senior IP Director, OPPO, Katie Coltart, Partner, Linklaters, Laura Whiting, Partner, Freshfields, Liz Cohen, Partner, Bristows, Matthew Naylor, Partner, Mewburn Ellis, Patricia Paias, Partner, Antas da Cunha, Paul Inman, Partner, Gowling, Peter Finnie, Partner, Potter Clarkson, Philipp Cepl, Partner, DLA Piper, Pierre-Emmanuel Meynard – Partner, Lavoix, Rebecca Lawrence, Partner, DLA Piper, Sabine Age, Partner, Hoyng Rokh Monegier, Slorian Schmidt Bogatzy, HSF Kramer, Steven Baldwin, Partner, Kirkland and Ellis, Tatiana Alvez, Partner, RNA Law, Tess Waldren, Partner, Powell Gilbert, Tjibbe Douma, Partner, Bird and Bird, Tobias Wuttke, Partner, Bardehle Pagenberg, Tom Brown, Head of IP Litigation, Intel, Viviane Kunisawa, Partner, Daniel Law
The event opens on Monday 19 January with the UPC Litigation Forum, a full-day cross-sector pre-conference dedicated to deep analysis of early UPC rulings, procedural developments, and judicial insights. Sessions will explore the doctrine of equivalents, claim construction, injunction strategies, and the evolving reach of the UPC's jurisdiction. Featuring UPC judges and leading counsel, this pre-day forum provides an exclusive opportunity for attendees to understand the decision-making processes shaping Europe's newest patent court and to benchmark their litigation strategy against peers across industries.
From Tuesday 20 to Wednesday 21 January, the summit divides into two concurrent tracks, allowing attendees to tailor their experience according to their sector focus.
The Pharma and Biotech Patent Litigation Europe stream returns for its fifth year as the region's premier meeting for innovators, biosimilar manufacturers, and generic companies. Topics include cross-border litigation strategy, second medical use case law, plausibility following G2/21, SPC and PTE litigation, Bolar exemptions, and the evolving impact of the proposed EU pharmaceutical package. Sessions led by senior in-house counsel and judges will address pressing challenges such as preliminary injunctions in fast-moving markets, regulatory exclusivity, illicit compounding, and settlement strategy in a post-UPC world. This track attracts IP leaders from companies such as Sandoz, Fresenius Kabi, MSD, Novartis, Novo Nordisk, Regeneron, and Bayer, offering a uniquely balanced discussion across the innovator and generic sides of the market.
Running in parallel, the Tech and Innovation Patent Litigation Europe stream debuts in 2026, reflecting Europe's rapidly expanding litigation landscape in technology, telecommunications, automotive, and consumer electronics. The agenda explores SEP and FRAND enforcement, AI-related IP disputes, trade secrets, injunction power in key jurisdictions, and cross-border forum selection under the UPC and national courts. With participation from leading global IP figures including Nokia, Ericsson, Qualcomm, Xiaomi, Huawei, Cisco, TomTom, and ASML, this stream provides an unparalleled opportunity to understand the dynamics of patent monetisation, global FRAND rate setting, and regulatory developments shaping licensing and enforcement.
Across both tracks, the event maintains a 45% in-house counsel ratio, ensuring attendees benefit from commercially valuable networking and insight exchange with decision-makers who drive litigation and instruct external counsel. The summit attracts over 800 professionals, including corporate IP leaders, patent litigation partners from top European and international firms, litigation funders, and regulatory specialists. Delegates have access to shared networking spaces, curated roundtable discussions, and pre-scheduled one-to-one meetings, fostering meaningful new business connections and collaboration opportunities.
Key confirmed speakers and panellists include Julia Pike (Sandoz), Corinna Sundermann (Fresenius Kabi), James Horgan (MSD), Ronny Thomas (UPC Local Division Judge), Clemens Heusch (Nokia), Gabriele Mohsler (Ericsson), Le Chen (Xiaomi), Georg Müller (TomTom), Ief Daems (Cisco), and Wolfram Thomas (Qualcomm), alongside UPC judges from the Courts of Appeal and First Instance. Their participation underscores the summit's reputation as the foremost forum for discussion and practical guidance on European patent litigation.
URLs:
Website: https://go.evvnt.com/3302704-0?pid=2874
Exhibitor: https://go.evvnt.com/3302704-4?pid=2874
Category: Conferences | Business and Economics | Legal
Prices:
Tier 1 - In-House Counsel: EUR 499.00,
Tier 2 - Private Practice: EUR 1999.00,
Tier 3 - Solution Providers: EUR 2999.00
Speakers: Adrian Spillmann, Director of IP, Valneva, Andreas Robinson, Senior Counsel- IP and Litigation Law, Amgen, Beatriz Diaz de Escauriaza, Head of IP Legal, Insud Pharma, Carsten Richter, Head of Division IP, Euroimmun, Cecile Teles, Head of IP, Zentiva, Christoph Rehfuess, Head of IP, Sotio, Corinna Sundermann, Fresenius Kabi, Elisabeth Haselhorst, IP Litigation Counsel, Bayer, Ewan Nettleton, Principal IP Counsel- Oncology Litigation, Novartis, Fiona Bor, VP- Intellectual Property, Bicycle Therapeutics, George Moore, Assistant General Counsel, Viatris, Guido Pontremoli, Vice President Global IP, Chiesi, James Horgan, Chief IP Counsel- Policy and Litigation, MSD, James Robertson, Head of Global IP, bioMérieux, Julia Pike, Global Head of IP, Sandoz, Karin Pramberger, Head of IP, Polpharma, Katherine Hinterburg, Senior Director- Patent Litigation, Moderna, Konstantina Koriatopoulou, Director of IP, Elpen, Laila Beynon, Regeneron, Manuel Neetz, IP Counsel, Siemens Healthineers, Markus Gruber, Head IP Solid Tumours and Radioligland Therapies, Novartis, Matthew O'Neill, Head of IP, Glenmark, Michal Porubsky, Associate General Counsel, Novo Nordisk, Philippe Bessiere, Global Head of Patents, Pierre Fabre, Raquel Frisardi, Associate General Counsel, Novo Nordisk, Sean Alexander, Head of IP, Umicore, Shohta Ueno, Associate General Counsel- Dispute Resolution, Regeneron, Toni Santamaria, Chief IP Officer, Adalvo, Aoife Murphy, Partner, DLA Piper, Aude Veinante – Partner, Lavoix, Axel Berger, Partner, Bardehle Pagenberg, Camille Pecnard – Partner, Lavoix, Chris, Dudzinski, Parner, SDP, Claudia Milbradt, Partner, Clifford Chance, Dan McGrath, Managing Associate, Marks and Clark, Daniel Hoppe, Partner, Bonabry, Daniel Lim, Partner, Kirkland and Ellis, Dawid Sierzant, Partner, SDP Legal, Eleanor Root, Partner, Bird and Bird, Emre Kerim Yardımcı, Senior Partner, Deris, Eva Ehlich, Partner, Maiwald, James Holtom, Partner, McCarthy Tetrault, Jin Ooi, Partner, Kirkland and Ellis, John Cox Partner, Barnes and Thornburg, Katherine Helm, Partner, Dechert, Kokularajah Paheenthararajah, Partner, DLA Piper, Lauren Baker, Partner, Barnes and Thornburg, Maria Balestriero, of Counsel, Portolano Cavallo, Mariusz Kondrat, Managing Partner, Kondrat and Partners, Mike Gilbert, Partner, Marks and Clark, Okan Can, Senior Partner, Deris, Özge Atılgan Karakulak, Partner, Gun and Partners, Paul Ainsworth, Director, Sterne Kessler, Paul Inman, Partner, Gowling, Peter Van Schijndel, Partner, Hoyng Rokh Monegier, Pierre-Emmanuel Meynard – Partner, Lavoix, Richard Roberts, Partner, Potter Clarkson, Rob Rodrigues, Partner, RNA Law, Rutger Kleemans, Partner, Freshfields, Sebastian Moore, Partner, HSF Kramer, Selin Sinem Erciyas, Partner, Gun and Partners, Selma Ünlü, Senior Partner, NSN Law Firm, Siddharth Kusumakar, Partner, Powell Gilbert, Viviane Kunisawa, Partner, Daniel Law, Adele Calamo Specchia, Head of Ownership and Licensing, ASML, Adrian Howes,Head of IP and Standards- IP Policy, Nokia, Alexander Haertel, Cluster Lead Patents, Deutsch Telekom, Bas Van Buul, Director of IP, Inalfa Roof Systems, Beatriz Diaz de Escauriaza, Head of IP Legal, Insud Pharma, Bita Mortazavi, Vice President, Patent Analysis, RPX, Clemens Heusch, Global Head of Dispute Resolution, Nokia, David Goodfellow, Chief IP Counsel, Aptiv, Ewan Nettleton, Principal IP Counsel- Oncology Litigation, Novartis, Farnaz Massoumian, Senior Patent Attorney, Vodafone, Gabriele Mohsler, VP Patent Development, Ericsson, Georg Muller, Head of IP, Tom Tom, Ief Daems, Associate General Counsel, Cisco, Jako Elevald, Head of IP Licensing, Philips, Julia Dias, Senior IP Policy Counsel, Huawei, Koenraad Wuyds, Chief IP Officer, KPN, Le Chen, Senior Director- IP Policy and Dispute Resolution, Xiaomi Technology, Louis Ross, CEO, MEI Micro, Manuel Neetz, IP Counsel, Siemens Healthineers, Mitsuaki Masumura, Head of Licensing EMEA, IBM, Sean Alexander, Head of IP, Umicore, Taylor Ludlam, VP- IP and Litigation, Lenovo, Tom Brown, Head of IP Litigation, Dell, Wolfram Thomas, Senior Director- Patent Counsel, Qualcomm, Yann Dietrich, Group Head of IP, Atos, Antje Brambrink, Partner, Finnegan, Aude Veinante – Partner, Lavoix, Ben Elacqua, Principal, Fish and Richardson, Camille Pecnard – Partner, Lavoix, Carl-Alexander Dinges, Partner, Bonabry, Daan de Lange, Partner, Brinkhof, Dan McGrath, Managing Associate, Marks and Clark, Emily Bottle, Partner, HSF Kramer, Florian Schmidt-Bogatzky, Partner, HSF Kramer, Gary Moss, Chairman, EIP, Julia Schönbohm, Partner, Linklaters, Julia Zhu, Senior IP Director, OPPO, Katie Coltart, Partner, Linklaters, Laura Whiting, Partner, Freshfields, Liz Cohen, Partner, Bristows, Matthew Naylor, Partner, Mewburn Ellis, Patricia Paias, Partner, Antas da Cunha, Paul Inman, Partner, Gowling, Peter Finnie, Partner, Potter Clarkson, Philipp Cepl, Partner, DLA Piper, Pierre-Emmanuel Meynard – Partner, Lavoix, Rebecca Lawrence, Partner, DLA Piper, Sabine Age, Partner, Hoyng Rokh Monegier, Slorian Schmidt Bogatzy, HSF Kramer, Steven Baldwin, Partner, Kirkland and Ellis, Tatiana Alvez, Partner, RNA Law, Tess Waldren, Partner, Powell Gilbert, Tjibbe Douma, Partner, Bird and Bird, Tobias Wuttke, Partner, Bardehle Pagenberg, Tom Brown, Head of IP Litigation, Intel, Viviane Kunisawa, Partner, Daniel Law
Starting Price Per Person
€ 499.00 EUR
Other Information
Where
Beurs van Berlage
243 Damrak
Amsterdam Noord-Holland 1012 ZJ
Netherlands
( Multi-Purpose Events Venue )
243 Damrak
Amsterdam Noord-Holland 1012 ZJ
Netherlands
( Multi-Purpose Events Venue )
Event Organizer Contact
More Events
Event ID: 259658
Get Events in Your Inbox
We have over 100,000 Events in 80+ Categories. Tell us what type of events you like, and we will send them to your inbox